Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $1,017.24, with a 24-hour trading volume of $2.05B. The asset's market cap is $907.12B, after moving -0.25% in the last day.
Tokenized Eli Lilly And Co is trading at $1,018.01, with a tokenized market cap of $5.7M and a 24-hour trading volume of $2M. The tokenized asset has moved -0.05% in the past 24 hours.